Combination therapy for the treatment of ocular neovascular disorders
US8685397B2 · kind B2 · utility
5Cited by
66References
22Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 17, 2009 |
| Grant date | Apr 1, 2014 |
| Priority date | — |
| Expiry date | Aug 16, 2030 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2039/505
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention features methods for treating a patient diagnosed with, or at risk of developing, a neovascular disorder by administering a PDGF antagonist and a VEGF antagonist to the patient. The invention also features a pharmaceutical composition containing a PDGF antagonist and a VEGF antagonist for the treatment or prevention of a neovascular disorder.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.